These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25202075)

  • 21. MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In Vitro.
    Umbreit C; Erben P; Faber A; Hofheinz RD; Aderhold C; Weiss C; Hoermann K; Wenzel A; Schultz JD
    Anticancer Res; 2015 Jul; 35(7):3801-10. PubMed ID: 26124325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src.
    Kramer B; Kneissle M; Birk R; Rotter N; Aderhold C
    Anticancer Res; 2018 May; 38(5):2723-2731. PubMed ID: 29715092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reflux induces DNA strand breaks and expression changes of MMP1+9+14 in a human miniorgan culture model.
    Sandner A; Illert J; Koitzsch S; Unverzagt S; Schön I
    Exp Cell Res; 2013 Nov; 319(19):2905-15. PubMed ID: 24075964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
    Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
    J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Tyrosine Kinase Inhibitors and Everolimus on TGFβ1 and TGF-β Receptor 2 in Squamous Cell Carcinoma Cells.
    Huber L; Knüttel MT; Kramer B; Zaubitzer L; Lammert A; Scherl C; Rotter N; Häussler D
    Anticancer Res; 2024 Aug; 44(8):3287-3294. PubMed ID: 39060052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
    Yoo GH; Piechocki MP; Ensley JF; Nguyen T; Oliver J; Meng H; Kewson D; Shibuya TY; Lonardo F; Tainsky MA
    Clin Cancer Res; 2002 Dec; 8(12):3910-21. PubMed ID: 12473607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
    Beck TN; Smith CH; Flieder DB; Galloway TJ; Ridge JA; Golemis EA; Mehra R
    Head Neck; 2017 Mar; 39(3):E34-E39. PubMed ID: 27859938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
    Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression.
    Huber L; Birk R; Knuettel M; Rotter N; Aderhold C; Scherl C; Lammert A; Jungbauer F; Kramer B
    Anticancer Res; 2022 Jul; 42(7):3403-3411. PubMed ID: 35790279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
    Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
    Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC.
    Eytan DF; Snow GE; Carlson SG; Schiltz S; Chen Z; Van Waes C
    Laryngoscope; 2015 Mar; 125(3):E118-24. PubMed ID: 25431358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
    Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XRP6258-induced gene expression patterns in head and neck cancer carcinoma.
    Yoo GH; Kafri Z; Ensley JF; Lonardo F; Kim H; Folbe AJ; Won J; Stevens T; Lin HS
    Laryngoscope; 2010 Jun; 120(6):1114-9. PubMed ID: 20513026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.
    Higuchi E; Oridate N; Homma A; Suzuki F; Atago Y; Nagahashi T; Furuta Y; Fukuda S
    Head Neck; 2007 Oct; 29(10):940-7. PubMed ID: 17563903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
    Hira-Miyazawa M; Nakamura H; Hirai M; Kobayashi Y; Kitahara H; Bou-Gharios G; Kawashiri S
    Int J Oncol; 2018 Feb; 52(2):379-388. PubMed ID: 29345283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES; Whigham AS; Yarbrough WG; Weaver AM
    Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual role for p16 in the metastasis process of HPV positive head and neck cancers.
    Dok R; Glorieux M; Holacka K; Bamps M; Nuyts S
    Mol Cancer; 2017 Jun; 16(1):113. PubMed ID: 28662664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
    Li SH; Lin WC; Huang TL; Chen CH; Chiu TJ; Fang FM; Huang WT; Hsu CM; Luo SD; Lai CC; Su YY; Chuang HC; Chien CY
    Head Neck; 2016 Apr; 38 Suppl 1():E844-52. PubMed ID: 25917382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
    Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
    Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.